Guangdong Hybribio BiotechLtd Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jianyu Wang
Chief executive officer
CN¥2.0m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.3yrs |
| CEO ownership | n/a |
| Management average tenure | 7.3yrs |
| Board average tenure | 7.9yrs |
Recent management updates
Recent updates
CEO
Jianyu Wang (63 yo)
2.3yrs
Tenure
CN¥2,028,700
Compensation
Ms. Jianyu Wang is the General Manager at Guangdong Hybribio Biotech Co.,Ltd. since August 31, 2022 and was its Executive Deputy General Manager until August 31, 2022. She has been Director at Guangdong Hy...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 2.3yrs | CN¥2.03m | no data | |
| Finance Director & Accounting Supervisor | 10.7yrs | CN¥671.50k | 0.0072% CN¥ 291.9k | |
| Deputy GM & Director | 14.3yrs | CN¥1.15m | 0.059% CN¥ 2.4m | |
| Executive Deputy GM & Non Independent Director | no data | CN¥2.97m | 0.57% CN¥ 23.3m | |
| Deputy GM & Board Secretary | no data | CN¥715.90k | 0.013% CN¥ 519.0k | |
| Deputy General Manager | 3.9yrs | CN¥720.50k | 0.0056% CN¥ 226.7k |
7.3yrs
Average Tenure
49.5yo
Average Age
Experienced Management: 300639's management team is seasoned and experienced (7.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Director | 8.3yrs | CN¥2.03m | no data | |
| Deputy GM & Director | 4.2yrs | CN¥1.15m | 0.059% CN¥ 2.4m | |
| Executive Deputy GM & Non Independent Director | 14.3yrs | CN¥2.97m | 0.57% CN¥ 23.3m | |
| Supervisor | 7.5yrs | no data | no data | |
| Vice Chairman of the Board | 14.3yrs | CN¥300.00k | no data | |
| Director | 14.3yrs | CN¥120.00k | no data | |
| Chairman of the Board | 14.3yrs | CN¥2.17m | no data | |
| Employee Representative Supervisor | 11.3yrs | no data | no data | |
| Chairman of the Supervisory Board | 5.3yrs | no data | no data | |
| Independent Director | 2.3yrs | CN¥120.00k | no data | |
| Independent Director | 2.3yrs | CN¥120.00k | no data | |
| Independent Director | 2.3yrs | CN¥120.00k | no data |
7.9yrs
Average Tenure
60.5yo
Average Age
Experienced Board: 300639's board of directors are considered experienced (7.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 08:22 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Guangdong Hybribio Biotech Co.,Ltd. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hanqing Zhu | Guosen Securities Co., Ltd. |
| Jiaxi Xu | Industrial Securities Co. Ltd. |
| Jiaqi Zhu | Zhongtai Securities Co. Ltd. |